Learn More
Medchemexpress LLC Glimepiride | 93479-97-1 | 99.9% | C24H34N4O5S | 5 G

Supplier: Medchemexpress LLC HYB01045G
Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic compound. It has shown to lower blood glucose more effectively than glibenclamide and may decrease extracellular Aβ40 and Aβ42 levels, suggesting its potential for Alzheimer's disease associated with diabetes.
- Medium-to-long acting sulfonylurea anti-diabetic compound.
- Lower risk of hypoglycemia and less weight gain compared to other sulfonylureas.
- May be safer for patients with cardiovascular disease due to a lack of detrimental effects on ischemic preconditioning.
- Potential for Alzheimer's disease associated with diabetes by decreasing extracellular Aβ40 and Aβ42 levels.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.